New CD19-targeted treatment for patients non-Hodgkin B-cell lymphomas
What is it about?
Expression of CD19 on B cell non-Hodgkin lymphoma has identified it as a potential target for immune-based therapies. Various types of CD19 targeted treatments are reviewed and discussed
Why is it important?
Targeted treatments for non-Hodgkin lymphoma often reduce the off-target side effects of conventional chemotherapy, but may cause other unexpected side-effects. These are discussed in this review.
The following have contributed to this page: Dr. Marcus Watkins